Your milestones, our mission Founded to expedite biopharmaceutical value creation and help patients, D2V Clinical aims to lend a hand toward eradicating diseases with unmet medical needs. Our leaders are known for moving the industry forward. D2V Clinical is the early-phase oncology, hematology and rare disease development partner for biotech companies in the US and China. We are a full-service global CRO offering world-class clinical development insight and end-to-end capabilities combined with a robust PI network and EMR data access to expedite enrollment. With more than 20 years of leadership in oncology clinical research and investor value creation, we bring the depth of knowledge required to value your asset, connect your studies to the right patient populations and sites, and conduct an efficient and seamless study – all with speed, efficiency, and quality. Let our poise, expertise, and relationship-driven approach give you the confidence to expedite drug signal detection and advance your program in the US or China. • An array of successful global marketing approval submissions • Engaging stakeholders and removing barriers throughout drug development • Helping you predict issues and risks in advance to avoid delays and surprises